← Open Payments lookup

ABIGAIL RANDALL: Open Payments

NPI 1104443308 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$934 in 35 payments from 14 companies in 2025. Trend: 2023 $135 · 2024 $246 · 2025 $934

Food & beverage: $934
CompanyPaymentsAmount
Biogen, Inc.2$142
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$128
Vanda Pharmaceuticals Inc.5$124
Neurocrine BioSciences, Inc.4$110
Lundbeck LLC4$107
E.R. Squibb & Sons, L.L.C.3$78
Otsuka America Pharmaceutical, Inc.4$76
Axsome Therapeutics, Inc.2$50
Noven Therapeutics, LLC2$35
Collegium Pharmaceutical, Inc.1$19

Products named: REXULTI, ZURZUVAE, CAPLYTA, INGREZZA, FANAPT, COBENFY, Auvelity, Xelstrym.

Industry payments across TN — which companies pay providers there.